Table of Content

1 Study Coverage
1.1 Genetically Modified Drug Product Introduction
1.2 Market by Type
1.2.1 Global Genetically Modified Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Transgenic Animal
1.2.3 Transgenic Plant
1.3 Market by Application
1.3.1 Global Genetically Modified Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Genetically Modified Drug Sales Estimates and Forecasts 2018-2029
2.2 Global Genetically Modified Drug Revenue by Region
2.2.1 Global Genetically Modified Drug Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Genetically Modified Drug Revenue by Region (2018-2024)
2.2.3 Global Genetically Modified Drug Revenue by Region (2024-2029)
2.2.4 Global Genetically Modified Drug Revenue Market Share by Region (2018-2029)
2.3 Global Genetically Modified Drug Sales Estimates and Forecasts 2018-2029
2.4 Global Genetically Modified Drug Sales by Region
2.4.1 Global Genetically Modified Drug Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Genetically Modified Drug Sales by Region (2018-2024)
2.4.3 Global Genetically Modified Drug Sales by Region (2024-2029)
2.4.4 Global Genetically Modified Drug Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Genetically Modified Drug Sales by Manufacturers
3.1.1 Global Genetically Modified Drug Sales by Manufacturers (2018-2024)
3.1.2 Global Genetically Modified Drug Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Genetically Modified Drug in 2022
3.2 Global Genetically Modified Drug Revenue by Manufacturers
3.2.1 Global Genetically Modified Drug Revenue by Manufacturers (2018-2024)
3.2.2 Global Genetically Modified Drug Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Genetically Modified Drug Revenue in 2022
3.3 Global Key Players of Genetically Modified Drug, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Genetically Modified Drug Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Genetically Modified Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Genetically Modified Drug, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Genetically Modified Drug, Product Offered and Application
3.8 Global Key Manufacturers of Genetically Modified Drug, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Genetically Modified Drug Sales by Type
4.1.1 Global Genetically Modified Drug Historical Sales by Type (2018-2024)
4.1.2 Global Genetically Modified Drug Forecasted Sales by Type (2024-2029)
4.1.3 Global Genetically Modified Drug Sales Market Share by Type (2018-2029)
4.2 Global Genetically Modified Drug Revenue by Type
4.2.1 Global Genetically Modified Drug Historical Revenue by Type (2018-2024)
4.2.2 Global Genetically Modified Drug Forecasted Revenue by Type (2024-2029)
4.2.3 Global Genetically Modified Drug Revenue Market Share by Type (2018-2029)
4.3 Global Genetically Modified Drug Price by Type
4.3.1 Global Genetically Modified Drug Price by Type (2018-2024)
4.3.2 Global Genetically Modified Drug Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Genetically Modified Drug Sales by Application
5.1.1 Global Genetically Modified Drug Historical Sales by Application (2018-2024)
5.1.2 Global Genetically Modified Drug Forecasted Sales by Application (2024-2029)
5.1.3 Global Genetically Modified Drug Sales Market Share by Application (2018-2029)
5.2 Global Genetically Modified Drug Revenue by Application
5.2.1 Global Genetically Modified Drug Historical Revenue by Application (2018-2024)
5.2.2 Global Genetically Modified Drug Forecasted Revenue by Application (2024-2029)
5.2.3 Global Genetically Modified Drug Revenue Market Share by Application (2018-2029)
5.3 Global Genetically Modified Drug Price by Application
5.3.1 Global Genetically Modified Drug Price by Application (2018-2024)
5.3.2 Global Genetically Modified Drug Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Genetically Modified Drug Market Size by Type
6.1.1 US & Canada Genetically Modified Drug Sales by Type (2018-2029)
6.1.2 US & Canada Genetically Modified Drug Revenue by Type (2018-2029)
6.2 US & Canada Genetically Modified Drug Market Size by Application
6.2.1 US & Canada Genetically Modified Drug Sales by Application (2018-2029)
6.2.2 US & Canada Genetically Modified Drug Revenue by Application (2018-2029)
6.3 US & Canada Genetically Modified Drug Market Size by Country
6.3.1 US & Canada Genetically Modified Drug Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Genetically Modified Drug Sales by Country (2018-2029)
6.3.3 US & Canada Genetically Modified Drug Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Genetically Modified Drug Market Size by Type
7.1.1 Europe Genetically Modified Drug Sales by Type (2018-2029)
7.1.2 Europe Genetically Modified Drug Revenue by Type (2018-2029)
7.2 Europe Genetically Modified Drug Market Size by Application
7.2.1 Europe Genetically Modified Drug Sales by Application (2018-2029)
7.2.2 Europe Genetically Modified Drug Revenue by Application (2018-2029)
7.3 Europe Genetically Modified Drug Market Size by Country
7.3.1 Europe Genetically Modified Drug Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Genetically Modified Drug Sales by Country (2018-2029)
7.3.3 Europe Genetically Modified Drug Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Genetically Modified Drug Market Size
8.1.1 China Genetically Modified Drug Sales (2018-2029)
8.1.2 China Genetically Modified Drug Revenue (2018-2029)
8.2 China Genetically Modified Drug Market Size by Application
8.2.1 China Genetically Modified Drug Sales by Application (2018-2029)
8.2.2 China Genetically Modified Drug Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Genetically Modified Drug Market Size by Type
9.1.1 Asia Genetically Modified Drug Sales by Type (2018-2029)
9.1.2 Asia Genetically Modified Drug Revenue by Type (2018-2029)
9.2 Asia Genetically Modified Drug Market Size by Application
9.2.1 Asia Genetically Modified Drug Sales by Application (2018-2029)
9.2.2 Asia Genetically Modified Drug Revenue by Application (2018-2029)
9.3 Asia Genetically Modified Drug Sales by Region
9.3.1 Asia Genetically Modified Drug Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Genetically Modified Drug Revenue by Region (2018-2029)
9.3.3 Asia Genetically Modified Drug Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Genetically Modified Drug Market Size by Type
10.1.1 Middle East, Africa and Latin America Genetically Modified Drug Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Genetically Modified Drug Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Genetically Modified Drug Market Size by Application
10.2.1 Middle East, Africa and Latin America Genetically Modified Drug Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Genetically Modified Drug Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Genetically Modified Drug Sales by Country
10.3.1 Middle East, Africa and Latin America Genetically Modified Drug Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Genetically Modified Drug Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Genetically Modified Drug Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 LFB Biotechnologies SA
11.1.1 LFB Biotechnologies SA Company Information
11.1.2 LFB Biotechnologies SA Overview
11.1.3 LFB Biotechnologies SA Genetically Modified Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 LFB Biotechnologies SA Genetically Modified Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 LFB Biotechnologies SA Recent Developments
11.2 Pharming Group NV
11.2.1 Pharming Group NV Company Information
11.2.2 Pharming Group NV Overview
11.2.3 Pharming Group NV Genetically Modified Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Pharming Group NV Genetically Modified Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Pharming Group NV Recent Developments
11.3 Pfizer
11.3.1 Pfizer Company Information
11.3.2 Pfizer Overview
11.3.3 Pfizer Genetically Modified Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Pfizer Genetically Modified Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Pfizer Recent Developments
11.4 Roche
11.4.1 Roche Company Information
11.4.2 Roche Overview
11.4.3 Roche Genetically Modified Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Roche Genetically Modified Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Roche Recent Developments
11.5 Abbott Laboratories
11.5.1 Abbott Laboratories Company Information
11.5.2 Abbott Laboratories Overview
11.5.3 Abbott Laboratories Genetically Modified Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Abbott Laboratories Genetically Modified Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Abbott Laboratories Recent Developments
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Information
11.6.2 Johnson & Johnson Overview
11.6.3 Johnson & Johnson Genetically Modified Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Johnson & Johnson Genetically Modified Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Johnson & Johnson Recent Developments
11.7 Merck & Co.
11.7.1 Merck & Co. Company Information
11.7.2 Merck & Co. Overview
11.7.3 Merck & Co. Genetically Modified Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Merck & Co. Genetically Modified Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Merck & Co. Recent Developments
11.8 Amgen
11.8.1 Amgen Company Information
11.8.2 Amgen Overview
11.8.3 Amgen Genetically Modified Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Amgen Genetically Modified Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Amgen Recent Developments
11.9 F. Hoffmann-La Roche
11.9.1 F. Hoffmann-La Roche Company Information
11.9.2 F. Hoffmann-La Roche Overview
11.9.3 F. Hoffmann-La Roche Genetically Modified Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 F. Hoffmann-La Roche Genetically Modified Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 F. Hoffmann-La Roche Recent Developments
11.10 Sanofi
11.10.1 Sanofi Company Information
11.10.2 Sanofi Overview
11.10.3 Sanofi Genetically Modified Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Sanofi Genetically Modified Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Sanofi Recent Developments
11.11 Novartis
11.11.1 Novartis Company Information
11.11.2 Novartis Overview
11.11.3 Novartis Genetically Modified Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Novartis Genetically Modified Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Novartis Recent Developments
11.12 Eli Lilly
11.12.1 Eli Lilly Company Information
11.12.2 Eli Lilly Overview
11.12.3 Eli Lilly Genetically Modified Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Eli Lilly Genetically Modified Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Eli Lilly Recent Developments
11.13 Takeda
11.13.1 Takeda Company Information
11.13.2 Takeda Overview
11.13.3 Takeda Genetically Modified Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Takeda Genetically Modified Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Takeda Recent Developments
11.14 Baxter
11.14.1 Baxter Company Information
11.14.2 Baxter Overview
11.14.3 Baxter Genetically Modified Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 Baxter Genetically Modified Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Baxter Recent Developments
11.15 GlaxoSmithKline
11.15.1 GlaxoSmithKline Company Information
11.15.2 GlaxoSmithKline Overview
11.15.3 GlaxoSmithKline Genetically Modified Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.15.4 GlaxoSmithKline Genetically Modified Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 GlaxoSmithKline Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Genetically Modified Drug Industry Chain Analysis
12.2 Genetically Modified Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Genetically Modified Drug Production Mode & Process
12.4 Genetically Modified Drug Sales and Marketing
12.4.1 Genetically Modified Drug Sales Channels
12.4.2 Genetically Modified Drug Distributors
12.5 Genetically Modified Drug Customers
13 Market Dynamics
13.1 Genetically Modified Drug Industry Trends
13.2 Genetically Modified Drug Market Drivers
13.3 Genetically Modified Drug Market Challenges
13.4 Genetically Modified Drug Market Restraints
14 Key Findings in The Global Genetically Modified Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Genetically Modified Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Transgenic Animal
Table 3. Major Manufacturers of Transgenic Plant
Table 4. Global Genetically Modified Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Genetically Modified Drug Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Genetically Modified Drug Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Genetically Modified Drug Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Genetically Modified Drug Revenue Market Share by Region (2018-2024)
Table 9. Global Genetically Modified Drug Revenue Market Share by Region (2024-2029)
Table 10. Global Genetically Modified Drug Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Genetically Modified Drug Sales by Region (2018-2024) & (K Units)
Table 12. Global Genetically Modified Drug Sales by Region (2024-2029) & (K Units)
Table 13. Global Genetically Modified Drug Sales Market Share by Region (2018-2024)
Table 14. Global Genetically Modified Drug Sales Market Share by Region (2024-2029)
Table 15. Global Genetically Modified Drug Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Genetically Modified Drug Sales Share by Manufacturers (2018-2024)
Table 17. Global Genetically Modified Drug Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Genetically Modified Drug Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Genetically Modified Drug, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Genetically Modified Drug Price by Manufacturers 2018-2024 (US$/Unit)
Table 21. Global Genetically Modified Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Genetically Modified Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genetically Modified Drug as of 2022)
Table 23. Global Key Manufacturers of Genetically Modified Drug, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Genetically Modified Drug, Product Offered and Application
Table 25. Global Key Manufacturers of Genetically Modified Drug, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Genetically Modified Drug Sales by Type (2018-2024) & (K Units)
Table 28. Global Genetically Modified Drug Sales by Type (2024-2029) & (K Units)
Table 29. Global Genetically Modified Drug Sales Share by Type (2018-2024)
Table 30. Global Genetically Modified Drug Sales Share by Type (2024-2029)
Table 31. Global Genetically Modified Drug Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Genetically Modified Drug Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Genetically Modified Drug Revenue Share by Type (2018-2024)
Table 34. Global Genetically Modified Drug Revenue Share by Type (2024-2029)
Table 35. Genetically Modified Drug Price by Type (2018-2024) & (US$/Unit)
Table 36. Global Genetically Modified Drug Price Forecast by Type (2024-2029) & (US$/Unit)
Table 37. Global Genetically Modified Drug Sales by Application (2018-2024) & (K Units)
Table 38. Global Genetically Modified Drug Sales by Application (2024-2029) & (K Units)
Table 39. Global Genetically Modified Drug Sales Share by Application (2018-2024)
Table 40. Global Genetically Modified Drug Sales Share by Application (2024-2029)
Table 41. Global Genetically Modified Drug Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Genetically Modified Drug Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Genetically Modified Drug Revenue Share by Application (2018-2024)
Table 44. Global Genetically Modified Drug Revenue Share by Application (2024-2029)
Table 45. Genetically Modified Drug Price by Application (2018-2024) & (US$/Unit)
Table 46. Global Genetically Modified Drug Price Forecast by Application (2024-2029) & (US$/Unit)
Table 47. US & Canada Genetically Modified Drug Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Genetically Modified Drug Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Genetically Modified Drug Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Genetically Modified Drug Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Genetically Modified Drug Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Genetically Modified Drug Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Genetically Modified Drug Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Genetically Modified Drug Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Genetically Modified Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Genetically Modified Drug Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Genetically Modified Drug Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Genetically Modified Drug Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Genetically Modified Drug Sales by Country (2024-2029) & (K Units)
Table 60. Europe Genetically Modified Drug Sales by Type (2018-2024) & (K Units)
Table 61. Europe Genetically Modified Drug Sales by Type (2024-2029) & (K Units)
Table 62. Europe Genetically Modified Drug Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Genetically Modified Drug Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Genetically Modified Drug Sales by Application (2018-2024) & (K Units)
Table 65. Europe Genetically Modified Drug Sales by Application (2024-2029) & (K Units)
Table 66. Europe Genetically Modified Drug Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Genetically Modified Drug Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Genetically Modified Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Genetically Modified Drug Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Genetically Modified Drug Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Genetically Modified Drug Sales by Country (2018-2024) & (K Units)
Table 72. Europe Genetically Modified Drug Sales by Country (2024-2029) & (K Units)
Table 73. China Genetically Modified Drug Sales by Type (2018-2024) & (K Units)
Table 74. China Genetically Modified Drug Sales by Type (2024-2029) & (K Units)
Table 75. China Genetically Modified Drug Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Genetically Modified Drug Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Genetically Modified Drug Sales by Application (2018-2024) & (K Units)
Table 78. China Genetically Modified Drug Sales by Application (2024-2029) & (K Units)
Table 79. China Genetically Modified Drug Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Genetically Modified Drug Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Genetically Modified Drug Sales by Type (2018-2024) & (K Units)
Table 82. Asia Genetically Modified Drug Sales by Type (2024-2029) & (K Units)
Table 83. Asia Genetically Modified Drug Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Genetically Modified Drug Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Genetically Modified Drug Sales by Application (2018-2024) & (K Units)
Table 86. Asia Genetically Modified Drug Sales by Application (2024-2029) & (K Units)
Table 87. Asia Genetically Modified Drug Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Genetically Modified Drug Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Genetically Modified Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Genetically Modified Drug Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Genetically Modified Drug Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Genetically Modified Drug Sales by Region (2018-2024) & (K Units)
Table 93. Asia Genetically Modified Drug Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Genetically Modified Drug Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Genetically Modified Drug Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Genetically Modified Drug Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Genetically Modified Drug Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Genetically Modified Drug Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Genetically Modified Drug Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Genetically Modified Drug Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Genetically Modified Drug Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Genetically Modified Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Genetically Modified Drug Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Genetically Modified Drug Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Genetically Modified Drug Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Genetically Modified Drug Sales by Country (2024-2029) & (K Units)
Table 107. LFB Biotechnologies SA Company Information
Table 108. LFB Biotechnologies SA Description and Major Businesses
Table 109. LFB Biotechnologies SA Genetically Modified Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. LFB Biotechnologies SA Genetically Modified Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. LFB Biotechnologies SA Recent Developments
Table 112. Pharming Group NV Company Information
Table 113. Pharming Group NV Description and Major Businesses
Table 114. Pharming Group NV Genetically Modified Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. Pharming Group NV Genetically Modified Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Pharming Group NV Recent Developments
Table 117. Pfizer Company Information
Table 118. Pfizer Description and Major Businesses
Table 119. Pfizer Genetically Modified Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. Pfizer Genetically Modified Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Pfizer Recent Developments
Table 122. Roche Company Information
Table 123. Roche Description and Major Businesses
Table 124. Roche Genetically Modified Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Roche Genetically Modified Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Roche Recent Developments
Table 127. Abbott Laboratories Company Information
Table 128. Abbott Laboratories Description and Major Businesses
Table 129. Abbott Laboratories Genetically Modified Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. Abbott Laboratories Genetically Modified Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Abbott Laboratories Recent Developments
Table 132. Johnson & Johnson Company Information
Table 133. Johnson & Johnson Description and Major Businesses
Table 134. Johnson & Johnson Genetically Modified Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. Johnson & Johnson Genetically Modified Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Johnson & Johnson Recent Developments
Table 137. Merck & Co. Company Information
Table 138. Merck & Co. Description and Major Businesses
Table 139. Merck & Co. Genetically Modified Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. Merck & Co. Genetically Modified Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Merck & Co. Recent Developments
Table 142. Amgen Company Information
Table 143. Amgen Description and Major Businesses
Table 144. Amgen Genetically Modified Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 145. Amgen Genetically Modified Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Amgen Recent Developments
Table 147. F. Hoffmann-La Roche Company Information
Table 148. F. Hoffmann-La Roche Description and Major Businesses
Table 149. F. Hoffmann-La Roche Genetically Modified Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 150. F. Hoffmann-La Roche Genetically Modified Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. F. Hoffmann-La Roche Recent Developments
Table 152. Sanofi Company Information
Table 153. Sanofi Description and Major Businesses
Table 154. Sanofi Genetically Modified Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 155. Sanofi Genetically Modified Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Sanofi Recent Developments
Table 157. Novartis Company Information
Table 158. Novartis Description and Major Businesses
Table 159. Novartis Genetically Modified Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 160. Novartis Genetically Modified Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Novartis Recent Developments
Table 162. Eli Lilly Company Information
Table 163. Eli Lilly Description and Major Businesses
Table 164. Eli Lilly Genetically Modified Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 165. Eli Lilly Genetically Modified Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Eli Lilly Recent Developments
Table 167. Takeda Company Information
Table 168. Takeda Description and Major Businesses
Table 169. Takeda Genetically Modified Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 170. Takeda Genetically Modified Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Takeda Recent Developments
Table 172. Baxter Company Information
Table 173. Baxter Description and Major Businesses
Table 174. Baxter Genetically Modified Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 175. Baxter Genetically Modified Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. Baxter Recent Developments
Table 177. GlaxoSmithKline Company Information
Table 178. GlaxoSmithKline Description and Major Businesses
Table 179. GlaxoSmithKline Genetically Modified Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 180. GlaxoSmithKline Genetically Modified Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 181. GlaxoSmithKline Recent Developments
Table 182. Key Raw Materials Lists
Table 183. Raw Materials Key Suppliers Lists
Table 184. Genetically Modified Drug Distributors List
Table 185. Genetically Modified Drug Customers List
Table 186. Genetically Modified Drug Market Trends
Table 187. Genetically Modified Drug Market Drivers
Table 188. Genetically Modified Drug Market Challenges
Table 189. Genetically Modified Drug Market Restraints
Table 190. Research Programs/Design for This Report
Table 191. Key Data Information from Secondary Sources
Table 192. Key Data Information from Primary Sources
List of Figures
Figure 1. Genetically Modified Drug Product Picture
Figure 2. Global Genetically Modified Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Genetically Modified Drug Market Share by Type in 2022 & 2029
Figure 4. Transgenic Animal Product Picture
Figure 5. Transgenic Plant Product Picture
Figure 6. Global Genetically Modified Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Genetically Modified Drug Market Share by Application in 2022 & 2029
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Genetically Modified Drug Report Years Considered
Figure 11. Global Genetically Modified Drug Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Genetically Modified Drug Revenue 2018-2029 (US$ Million)
Figure 13. Global Genetically Modified Drug Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 14. Global Genetically Modified Drug Revenue Market Share by Region (2018-2029)
Figure 15. Global Genetically Modified Drug Sales 2018-2029 ((K Units)
Figure 16. Global Genetically Modified Drug Sales Market Share by Region (2018-2029)
Figure 17. US & Canada Genetically Modified Drug Sales YoY (2018-2029) & (K Units)
Figure 18. US & Canada Genetically Modified Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 19. Europe Genetically Modified Drug Sales YoY (2018-2029) & (K Units)
Figure 20. Europe Genetically Modified Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 21. China Genetically Modified Drug Sales YoY (2018-2029) & (K Units)
Figure 22. China Genetically Modified Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Asia (excluding China) Genetically Modified Drug Sales YoY (2018-2029) & (K Units)
Figure 24. Asia (excluding China) Genetically Modified Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Genetically Modified Drug Sales YoY (2018-2029) & (K Units)
Figure 26. Middle East, Africa and Latin America Genetically Modified Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 27. The Genetically Modified Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 28. The Top 5 and 10 Largest Manufacturers of Genetically Modified Drug in the World: Market Share by Genetically Modified Drug Revenue in 2022
Figure 29. Global Genetically Modified Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Global Genetically Modified Drug Sales Market Share by Type (2018-2029)
Figure 31. Global Genetically Modified Drug Revenue Market Share by Type (2018-2029)
Figure 32. Global Genetically Modified Drug Sales Market Share by Application (2018-2029)
Figure 33. Global Genetically Modified Drug Revenue Market Share by Application (2018-2029)
Figure 34. US & Canada Genetically Modified Drug Sales Market Share by Type (2018-2029)
Figure 35. US & Canada Genetically Modified Drug Revenue Market Share by Type (2018-2029)
Figure 36. US & Canada Genetically Modified Drug Sales Market Share by Application (2018-2029)
Figure 37. US & Canada Genetically Modified Drug Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Genetically Modified Drug Revenue Share by Country (2018-2029)
Figure 39. US & Canada Genetically Modified Drug Sales Share by Country (2018-2029)
Figure 40. U.S. Genetically Modified Drug Revenue (2018-2029) & (US$ Million)
Figure 41. Canada Genetically Modified Drug Revenue (2018-2029) & (US$ Million)
Figure 42. Europe Genetically Modified Drug Sales Market Share by Type (2018-2029)
Figure 43. Europe Genetically Modified Drug Revenue Market Share by Type (2018-2029)
Figure 44. Europe Genetically Modified Drug Sales Market Share by Application (2018-2029)
Figure 45. Europe Genetically Modified Drug Revenue Market Share by Application (2018-2029)
Figure 46. Europe Genetically Modified Drug Revenue Share by Country (2018-2029)
Figure 47. Europe Genetically Modified Drug Sales Share by Country (2018-2029)
Figure 48. Germany Genetically Modified Drug Revenue (2018-2029) & (US$ Million)
Figure 49. France Genetically Modified Drug Revenue (2018-2029) & (US$ Million)
Figure 50. U.K. Genetically Modified Drug Revenue (2018-2029) & (US$ Million)
Figure 51. Italy Genetically Modified Drug Revenue (2018-2029) & (US$ Million)
Figure 52. Russia Genetically Modified Drug Revenue (2018-2029) & (US$ Million)
Figure 53. China Genetically Modified Drug Sales Market Share by Type (2018-2029)
Figure 54. China Genetically Modified Drug Revenue Market Share by Type (2018-2029)
Figure 55. China Genetically Modified Drug Sales Market Share by Application (2018-2029)
Figure 56. China Genetically Modified Drug Revenue Market Share by Application (2018-2029)
Figure 57. Asia Genetically Modified Drug Sales Market Share by Type (2018-2029)
Figure 58. Asia Genetically Modified Drug Revenue Market Share by Type (2018-2029)
Figure 59. Asia Genetically Modified Drug Sales Market Share by Application (2018-2029)
Figure 60. Asia Genetically Modified Drug Revenue Market Share by Application (2018-2029)
Figure 61. Asia Genetically Modified Drug Revenue Share by Region (2018-2029)
Figure 62. Asia Genetically Modified Drug Sales Share by Region (2018-2029)
Figure 63. Japan Genetically Modified Drug Revenue (2018-2029) & (US$ Million)
Figure 64. South Korea Genetically Modified Drug Revenue (2018-2029) & (US$ Million)
Figure 65. China Taiwan Genetically Modified Drug Revenue (2018-2029) & (US$ Million)
Figure 66. Southeast Asia Genetically Modified Drug Revenue (2018-2029) & (US$ Million)
Figure 67. India Genetically Modified Drug Revenue (2018-2029) & (US$ Million)
Figure 68. Middle East, Africa and Latin America Genetically Modified Drug Sales Market Share by Type (2018-2029)
Figure 69. Middle East, Africa and Latin America Genetically Modified Drug Revenue Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Genetically Modified Drug Sales Market Share by Application (2018-2029)
Figure 71. Middle East, Africa and Latin America Genetically Modified Drug Revenue Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Genetically Modified Drug Revenue Share by Country (2018-2029)
Figure 73. Middle East, Africa and Latin America Genetically Modified Drug Sales Share by Country (2018-2029)
Figure 74. Brazil Genetically Modified Drug Revenue (2018-2029) & (US$ Million)
Figure 75. Mexico Genetically Modified Drug Revenue (2018-2029) & (US$ Million)
Figure 76. Turkey Genetically Modified Drug Revenue (2018-2029) & (US$ Million)
Figure 77. Israel Genetically Modified Drug Revenue (2018-2029) & (US$ Million)
Figure 78. GCC Countries Genetically Modified Drug Revenue (2018-2029) & (US$ Million)
Figure 79. Genetically Modified Drug Value Chain
Figure 80. Genetically Modified Drug Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed